Diagnostic Accuracy of Serum Procalcitonin to Diagnose Sepsis in Advanced Solid Tumor Patients with Fever
Abstract
Keywords
References
Zembower TR. Epidemiology of infections in cancer patients. Cancer Treat Res. 2014;161:43-89.
Zheng Y, Chen Y, Yu K, et al. Fatal infections among cancer patients: A population-based study in the United States. Infect Dis Ther. 2021;10(2):871-95.
Elfaituri MK, Morsy S, Tawfik GM, et al. Incidence of infection-related mortality in cancer patients: trend and survival analysis. J Clin Oncol. 2019;37:15(suppl):e23095
Taccone FS, Artigas AA, Sprung CL, et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13(1):R15.
Xiang MJ, Chen GL. Impact of cancer on mortality rates in patients with sepsis: A meta-analysis and meta-regression of current studies. World J Clin Cases. 2022;10(21):7386-96.
Pasikhova Y, Ludlow S, Baluch A. Fever in patients with cancer. Cancer Control. 2017;24(2):193-7.
Joudeh N, Sawafta E, Abu Taha A, et al. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country. BMC Infect Dis. 2023;23(1):106.
Nanayakkara AK, Boucher HW, Fowler VG Jr, et al. Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward. CA Cancer J Clin. 2021;71(6):488-504.
Qiu MZ, Xu RH, Ruan DY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31(6):633-41.
Aziz SA, Nelwan EJ, Sukrisman L, et al. Higher cut-off serum procalcitonin level for sepsis diagnosis in metastatic solid tumor patients. BMC Res Notes. 2018;11(1):84.
Matzaraki V, Alexandraki KI, Venetsanou K, et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem. 2007;40(5-6):336-42.
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250-1256.
World Health Organization. 360 Indonesia Fact Sheets GLOBOCAN 2020. 2020. https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf. Accessed 20 February 2023.
Agodirin O, Olatoke S, Rahman G, et al. Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria. PLoS One. 2021;16(11):e0256847.
Chaftari AM, Hachem R, Reitzel R, et al. Role of procalcitonin and interleukin-6 in predicting cancer, and its progression independent of infection. PLoS One. 2015;10(7):e0130999.
Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
Lan T, Chen L, Wei X. Inflammatory cytokines in cancer: Comprehensive understanding and clinical progress in gene therapy. Cells. 2021;10(1):100.
Michalaki V, Syrigos K, Charles P, et al. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004;90(12):2312-6.
Vassallo M, Michelangeli C, Fabre R, et al. Procalcitonin and C-reactive protein/procalcitonin ratio as markers of infection in patients with solid tumors. Front Med (Lausanne). 2021;8:627967.
Vincenzi B, Fioroni I, Pantano F, et al. Procalcitonin as a diagnostic marker of infection in solid tumor patients with fever. Sci Rep. 2016;6:28090.
Blouin AG, Hsu M, Fleisher M, Ramanathan LV, Pastores SM. Utility of procalcitonin as a predictor of bloodstream infections and supportive modality requirements in critically ill cancer patients. Clin Chim Acta. 2020;510:181-5.
Ding S, Ma J, Song X, et al. Diagnostic accuracy of procalcitonin, neutrophil-to-lymphocyte ratio, and c-reactive protein in detection of bacterial infections and prediction of outcome in nonneutropenic febrile patients with lung malignancy. J Oncol. 2020;2020:2192378.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10.
Refbacks
- There are currently no refbacks.